Categories: All postsAnalysts

Buy Real Matters stock for a double, ATB says

Real Matters is set for a stronger second half of the year, says ATB Capital Markets analyst Martin Toner, who believes improving mortgage volumes and potential new business wins could drive the stock higher.

Toner rates Real Matters (Real Matters Stock Quote, Chart, News, Analysts, Financials TSXV:REAL) as Outperform with a 12-month price target of $12.00.

In Toner’s preview of Real Matters’ upcoming Q2 fiscal 2025 results, scheduled for release on April 30, he expects revenue to decline slightly year-over-year, citing lingering effects from higher mortgage rates earlier in the year. However, he remains optimistic about Real’s long-term prospects, pointing to signs of resilience in its U.S. Appraisal segment, ongoing market share gains, and potential upside from new client additions in its Title business.

“We maintain our Outperform rating and $12.00 PT, keeping our near- and long-term estimates unchanged, given recent volatility in U.S. rates and mortgage volumes,” Toner said.

Toner noted that recent strong origination data from major U.S. banks like Wells Fargo and JP Morgan could provide a stronger backdrop for Real’s upcoming results. However, he cautioned that those results may not fully reflect across all of Real’s client base.

“We note that Wells Fargo Inc. (WFC-N, NR) and JP Morgan Inc. (JPM-N, NR) both reported strong y/y increases in origination volumes for Q1 (up 25% and 47% y/y, respectively),” he said. “Our estimates do not contemplate those gains to be typical across REAL’s customers. Our base case, however, remains for a more sustained recovery in H2/25. We will also be looking for indications of new customer wins in Title. We maintain our Outperform rating and $12.00 PT, keeping our near- and long-term estimates unchanged, given recent volatility in US rates and mortgage volumes.”

Toner thinks Real Matters will generate approximately $2.1-million in adjusted EBITDA on $189.4-million in revenue in fiscal 2025. He expects those numbers to improve to $37.4-million in adjusted EBITDA on $238.5-million in revenue in fiscal 2026.

“Our price target represents a 100.6% return to target, and is based on our discounted cash flow (DCF) valuation, using an 11.5% discount rate and 2.5% terminal growth rate (both unchanged),” Toner said. “Our discounted terminal value of $309mm represents 56.1% of total enterprise value (EV) of $551.4mm, as well as an 8.5x EV/EBITDA multiple, and a 1.4x EV/Revenue multiple.”

-30-

Tagged with: real
Rod Weatherbie

Rod Weatherbie is a journalist based in Prince Edward Island. Since 2004, he has written extensively about the Canadian property and casualty insurance landscape. He was also a founder and contributing editor for a Toronto-based arts website and a PEI-based food magazine. His fiction and poetry have been featured in The Fiddlehead, The Antigonish Review, and Juniper.

Recent Posts

Should you sell your Fortinet stock?

In a March 11 note, Roth Capital Partners analyst Taz Koujalgi maintained a “Neutral” rating and $90.00 price target on… [Read More]

1 day ago

This Canadian penny stock has 194% upside, analyst says

Beacon Securities analyst Donangelo Volpe maintained a “Speculative Buy” rating and $2.00 target on Sparq Systems (Sparq Systems Stock Quote,… [Read More]

1 day ago

Airbus SE is a buy, this investor says

Bruce Murray, CEO and CIO of Murray Wealth Group, told BNN Bloomberg Market Call on March 11 that Airbus SE… [Read More]

2 days ago

Is Rubrik stock a buy right now?

In a March 11 earnings preview, Roth Capital Partners analyst Taz Koujalgi said channel checks on Rubrik (Rubrik Stock Quote,… [Read More]

2 days ago

This pot stock keeps delivering, analyst says

Haywood Securities analyst Neal Gilmer maintained a “Buy” rating and $3.75 target price on Verano Holdings (Verano Holdings Stock Quote,… [Read More]

2 days ago

WELL Health could soon free up a ton of cash, Stifel says

In a March 9 report, Stifel Financial Corp. analyst Justin Keywood maintained a “Buy” rating and $9.00 target on WELL… [Read More]

2 days ago